Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial.

Julia von TresckowPaula CramerSandra RobrechtPetra LangerbeinsAnna-Maria FinkOthman Al-SawafMoritz FürstenauThomas IllmerHolger KlaprothEugen TauschMatthias RitgenKirsten FischerClemens-Martin WendtnerKarl-Anton KreuzerStephan StilgenbauerSebastian BöttcherBarbara F EichhorstMichael Hallek

Published in: Leukemia (2022)

Keyphrases

chronic lymphocytic leukemia
pet ct
clinical trial
study protocol
phase iii
big data
phase ii
deep learning